Phase III trial of subcutaneous epcoritamab + R-CHOP versus R-CHOP alone in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2 Meeting Abstract
| Authors: | Sehn, L.; Chamuleau, M.; Lenz, G.; Clausen, M.; Haioun, C.; Izutsu, K.; Davies, A.; Zhu, J.; Oki, T.; Szafer-Glusman, E.; Conlon, R.; Chiou, H. Y.; Ipe, D.; Elliott, B.; Wu, J.; Salles, G. |
| Abstract Title: | Phase III trial of subcutaneous epcoritamab + R-CHOP versus R-CHOP alone in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2 |
| Meeting Title: | 11th Annual Meeting of the Society of Hematologic Oncology (SOHO 2023): Progress in Personalized Therapy |
| Keywords: | dlbcl; phase iii; abcl; epcoritamab |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Sep 6-9 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S440 |
| Language: | English |
| ACCESSION: | WOS:001062479600466 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01333-2 |
| Notes: | Meeting Abstract: ABCL-517 -- Source: Wos |
